To understand the mechanism of action, we show that p21Cip1 level is suppressed in ACTL6A competent cells and is increased in ACTL6A knockout cells, suggesting that ACTL6A may maintain the cancer phenotype by suppressing p21Cip1 expression. This evidence concerns the gene CDKN1A and cancer.